Negara: Irlandia
Bahasa: Inggris
Sumber: HPRA (Health Products Regulatory Authority)
Ciprofloxacin hydrochloride
Bayer Limited
J01MA; J01MA02
Ciprofloxacin hydrochloride
250 milligram(s)
Film-coated tablet
Product subject to prescription which may not be renewed (A)
Fluoroquinolones; ciprofloxacin
Not marketed
1988-12-20
BP22059_REC30945 1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT CIPROXIN 250 MG FILM-COATED TABLETS Ciprofloxacin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Ciproxin is and what it is used for 2. What you need to know before you take Ciproxin 3. How to take Ciproxin 4. Possible side effects 5. How to store Ciproxin 6. Contents of the pack and other information 1. WHAT CIPROXIN IS AND WHAT IT IS USED FOR Ciproxin contains the active substance ciprofloxacin. Ciprofloxacin is an antibiotic belonging to the fluoroquinolone family. Ciprofloxacin works by killing bacteria that cause infections. It only works with specific strains of bacteria. Adults Ciproxin is used in adults to treat the following bacterial infections: • respiratory tract infections • long lasting or recurring ear or sinus infections • urinary tract infections • genital tract infections in men and women • gastro-intestinal tract infections and intra-abdominal infections • skin and soft tissue infections • bone and joint infections • to prevent infections due to the bacterium _Neisseria meningitidis_ • anthrax inhalation exposure Ciprofloxacin may be used in the management of patients with low white blood cell counts (neutropenia) who have a fever that is suspected to be due to a bacterial infection. If you have a severe infection or one that is caused by more than one type of bacterium, you may be given additional antibiotic treatment in addition to Ciproxin. BP22059_REC30945 2 Children and adolescents Baca dokumen lengkapnya
Health Products Regulatory Authority 30 March 2023 CRN00D80Z Page 1 of 20 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ciproxin 250 mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 250 mg ciprofloxacin (as hydrochloride) For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet Round, nearly white to slightly yellowish tablets marked with “CIP score 250” on one side and a Bayer cross on the reverse side. The tablets can be divided into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ciproxin 250 mg film-coated tablets are indicated for the treatment of the following infections (see sections 4.4 and 5.1). Special attention should be paid to available information on resistance to ciprofloxacin before commencing therapy. Consideration should be given to official guidance on the appropriate use of antibacterial agents. Adults Lower respiratory tract infections due to Gram-negative bacteria - exacerbation of chronic obstructive pulmonary disease. In exacerbation of chronic obstructive pulmonary disease Ciproxin should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections. - broncho-pulmonary infections in cystic fibrosis or in bronchiectasis - pneumonia Chronic suppurative otitis media Acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria Urinary tract infections - Uncomplicated acute cystitis. In uncomplicated acute cystitis Ciproxin should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections. - Acute pyelonephritis - Complicated urinary tract infections - Bacterial prostatitis Genital tract infections - gonococcal uretritis and cervicitis due to susceptible _Neisseria gonorrhoeae_ _ - _epididymo-orchitis including cases due to susceptible _ Baca dokumen lengkapnya